MERCURIUS 5 years Follow-Up: a follow-up study of a randomised, controlled, double-blind study to investigate the effects of a new infant formula given in the first 4 months of life on growth and body composition up to 5 years of age

MERCURIUS 5 years Follow-Up: a follow-up study of a randomised, controlled, double-blind study to investigate the effects of a new infant formula given in the first 4 months of life on growth and body composition up to 5 years of age - MERCURIUS 5 years Follow-Up study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON42552

Enrollment

100

Registered

2015-09-11

Start date

2016-01-27

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

effect op groei Effects on growth

Interventions

nvt

Eligibility

Age

2 Years to 11 Years

Inclusion criteria

Inclusion criteria: - Participation in the Mercurius study (NTR3683) up to visit 5 (4 months of age) - Written informed consent from parent(s) or legally acceptable representative(s)

Exclusion criteria

Exclusion criteria: - The Investigator's uncertainty about the willingness or ability of the child and parents to comply with the protocol requirements - Subjects of the Mercurius study (NTR3683) whose Principle Investigator chose not participate in the Mercurius 5 years Follow-Up study

Design outcomes

Primary

Measure	Time frame
Key outcome: Body Mass Index (BMI) at 3, 4, and 5 years of age	—

Secondary

Measure	Time frame
* Prevalence of overweight and obesity at 3, 4, and 5 years of age * Sum of skin fold thicknesses at 3, 4, and 5 years of age * Percentage total body fat (derived from skinfolds) * Head- and waist- circumference at 3, 4, and 5 years of age	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)